Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Cuts and ‘competitive pressures’ behind 72% Lloydspharmacy profit drop

Lloydspharmacy’s parent company has cited the funding cuts and “competitive pressures” in the UK as two reasons for a 72% drop in profits across its European business.

Adjusted operating profit for McKesson’s European pharmaceutical solutions division – which includes Lloydspharmacy – in the first three months of 2019 was $23 million (£17.7m), a 72% drop on the same period the previous year, it said in its latest financial report published this afternoon (May 8).

Revenue for this part of the business was up 2%, once currency rates were taken into account. While this increase had been “driven primarily by market growth”, it was “partially offset” by Lloydspharmacy’s decision to sell or close around 200 branches in England in 2018, as well as a “challenging market environment in the UK”.

C+D has previously identified 78 of the branches Lloydspharmacy closed in 2017-18, and another 104 that it sold.

Looking back over the past financial year, McKesson noted that adjusted operating profit for its European business was down 36% to $219m (£168m).

However, McKesson said it expects to see “modest improvement” in the UK business in 2020.

McKesson CEO Brian Tyler said the business had “successfully executed in a challenging environment and took action to address the headwinds in our European business”.

The latest results from McKesson come a month after Boots parent company Walgreens Boots Alliance said it was taking “immediate action” to address financial results “much weaker than expected”, which will include “decisive action” in the UK.

What do you make of the latest financial results results?

Related Content


Pharmacy Manager

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts